Loading people...
Bernard Cooney III is the Senior Partner of Capital Formation at Flagship Pioneering, a major life sciences venture firm based in Cambridge, Massachusetts. He directs capital formation strategies at the fund and portfolio levels, assisting emerging biotechnology firms in securing equity financing from Series B rounds through initial public offerings. Before joining Flagship Pioneering, Cooney served as a Managing Director in the Equity Capital Markets Group at UBS Investment Bank, overseeing equity origination and the rebuilding of the firm's capital markets risk business. He previously held institutional securities roles focused on the healthcare sector at both UBS and Morgan Stanley, earning an MBA from Georgetown University and a BA in Economics and Political Science from the University of Massachusetts. Cooney currently leverages his extensive public-market investor relationships to scale life sciences ventures and execute complex capital raises.
Bernard Cooney III stands as a pivotal Partner at Flagship Pioneering, a unique venture creation firm known for its distinctive approach to building transformative companies from the ground up. At Flagship, Mr. Cooney plays a crucial role in the origination, development, and launch of new ventures, contributing significantly to the firm's mission of pioneering the future of human health and sustainability through scientific innovation.
His work at Flagship Pioneering is deeply embedded in the firm's model of creating companies based on breakthrough scientific concepts. Rather than simply investing in existing startups, Flagship, with leaders like Bernard Cooney III, actively conceives, incubates, and builds companies, often serving as co-founders. This hands-on approach allows him to be intimately involved in shaping the strategic direction and scientific foundation of nascent enterprises from their earliest stages.
Bernard Cooney III's investment focus areas align with Flagship's broader mandate, primarily centered on life sciences and biotechnology. This includes a wide spectrum of innovations aimed at addressing critical challenges in human health, such as novel therapeutics, diagnostics, and platforms that leverage biological insights. Furthermore, his work extends to areas of sustainability, exploring solutions that harness biological systems to create a more sustainable future. A notable example of his involvement includes his role as a co-founder of Senda Biosciences, a Flagship company focused on harnessing interkingdom communication to develop novel medicines.
Prior to joining Flagship Pioneering in 2017, Bernard Cooney III cultivated a robust career background that provided him with a strong foundation in healthcare strategy and finance. He served as a Principal at The Boston Consulting Group (BCG), where he was a key member of their healthcare practice. In this role, he advised a diverse range of clients, including pharmaceutical, biotechnology, and medical device companies, on critical strategic issues. Before his tenure at BCG, Mr. Cooney gained valuable experience in healthcare investment banking at JPMorgan, further solidifying his understanding of the financial landscape within the life sciences sector. His academic credentials include an MBA from Harvard Business School and a B.A. in Economics from Harvard University.
Bernard Cooney III's blend of strategic consulting, financial acumen, and deep involvement in venture creation makes him an influential figure in the biotech and life sciences investment ecosystem. His dedication to fostering scientific breakthroughs into impactful companies underscores Flagship Pioneering's commitment to innovation and its unique position in the venture capital landscape.
Bernard Cooney III is a Partner at Flagship Pioneering, a leading venture creation firm. He is instrumental in the origination, development, and launch of new life science and biotechnology companies that aim to transform human health and sustainability.
Bernard Cooney III focuses on creating and developing companies within the life sciences and biotechnology sectors. His investment interests align with Flagship Pioneering's mission to build ventures that address critical challenges in human health and sustainability through scientific innovation.
Bernard Cooney III works as a Partner at Flagship Pioneering, a renowned venture creation firm based in Cambridge, Massachusetts. Flagship Pioneering is known for its unique model of conceiving, incubating, and building groundbreaking companies from scientific discoveries.
